TGF-β signaling was determined to be the main effective target of hepatic fibrosis because its activation leads to the differentiation of fibroblasts into contractile myofibroblasts, increased expression of α-SMA, and synthesis of extracellular matrix proteins. This evidence concerns the gene ACTA1 and Hepatic fibrosis.